Current opinion in urology · 2010
Current status of open partial nephrectomy.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Margreiter Markus, Marberger Michael
Аннотация
PURPOSE OF REVIEW: To assess the current status of open partial nephrectomy (OPN) for the treatment of renal tumors.
RECENT FINDINGS: Today, the standard indications for open nephron-sparing surgery are renal tumors in solitary kidneys, bilateral renal masses, tumors in patients with impaired renal function and unilateral masses smaller than 4 cm in diameter with a normal functioning contralateral kidney. For the latter, OPN is increasingly being challenged by laparoscopic partial nephrectomy, which in the hands of experts appears to achieve comparable oncological results, although at a higher complication rate. In selected situations, OPN appears justified in intermediate-risk patients with tumors up to 7 cm in diameter. Long-term outcome data indicate that OPN has cancer-free survival rates comparable to those of radical surgery with better preservation of renal function, decreased overall mortality and reduced frequency of cardiovascular events.
SUMMARY: OPN remains the standard of care for small renal masses and is increasingly advocated in selected patients with tumors up to 7 cm in diameter.
RECENT FINDINGS: Today, the standard indications for open nephron-sparing surgery are renal tumors in solitary kidneys, bilateral renal masses, tumors in patients with impaired renal function and unilateral masses smaller than 4 cm in diameter with a normal functioning contralateral kidney. For the latter, OPN is increasingly being challenged by laparoscopic partial nephrectomy, which in the hands of experts appears to achieve comparable oncological results, although at a higher complication rate. In selected situations, OPN appears justified in intermediate-risk patients with tumors up to 7 cm in diameter. Long-term outcome data indicate that OPN has cancer-free survival rates comparable to those of radical surgery with better preservation of renal function, decreased overall mortality and reduced frequency of cardiovascular events.
SUMMARY: OPN remains the standard of care for small renal masses and is increasingly advocated in selected patients with tumors up to 7 cm in diameter.